Intraoperative IV Iron on Postoperative Red Blood Cell Recovery
NCT ID: NCT04035902
Last Updated: 2020-08-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE4
46 participants
INTERVENTIONAL
2021-03-31
2021-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Does Intraoperative Intravenous Iron Enhance Postoperative Oxygenation Profile in Total Knee Arthroplasty Surgery?
NCT02544464
Iron Supplementation in Hip/Knee Surgery
NCT04078880
Effect of IV Iron Isomaltoside on Postoperative Anemia in Total Knee Arthroplasty Patients
NCT03470649
Iron and Vitamin Supplementation in Hip/Knee Surgery
NCT04880499
Iron and Vitamin Adminstration Prior to Joint Replacement to Prevent Transfusion
NCT01676740
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
ferric carboxymaltose 1000 mg
Ferric carboxymaltose is administered during surgery
Ferric carboxymaltose
Ferric carboxymaltose is administered during surgery
control
Ferric carboxymaltose is not administered
control
Ferric carboxymaltose is not administered
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ferric carboxymaltose
Ferric carboxymaltose is administered during surgery
control
Ferric carboxymaltose is not administered
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients provided a written informed consent.
* Patients with s-ferritin \< 300 mg/dl (male) or 200 mg/dl (female)
* Patients with preoperative serum hemoglobin concentration \>10 g/dL
Exclusion Criteria
* Patients received or receiving intraoperative and preoperative blood salvaged, allogenic blood transfusion, recombinant human erythropoietin, or undergoing acute normovolemic hemodilution.
20 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Konkuk University Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Tae-Yop Kim, MD PhD
Professor Anesthesiology
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KUH 2019-05-008
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.